Stem Cell Theory of Cancer: Implications of a Viral Etiology in Certain Malignancies

• Published in: Cancers 2021-06, Vol.13 (11), p.2738
• Main Author: Tu, Shi-Ming
• Format: Article
• Language: English
• Subjects: Autoimmunity; Cancer; Cell differentiation; Chronic illnesses; COVID-19; Embryos; Etiology; Experiments; Genomes; Hepatitis; Immune system; Infections; Inflammation; Liver cancer; Oncology; Ontogeny; Progenitor cells; Proto-oncogenes; Severe acute respiratory syndrome coronavirus 2; Stem cells; Tumorigenesis; Tumors; Viewpoint; Viral diseases; Viral infections; Viruses
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers13112738

In 1911, Peyton Rous (Nobel Prize winner in 1966) demonstrated that a virus (i.e., RSV) caused cancer in chickens. In 1976, Bishop and Varmus (Nobel Prize winners in 1989) showed that the cellular origin of retroviral oncogenes was actually normal cellular genes (i.e., proto-oncogenes). In this article, we revisit the role viruses play in the genetic origin of cancer. We review a link between viruses or cancer and autoimmunity in an alternative stem cell origin of cancer. We propose that a virus is more likely to cause cancer when it infects a progenitor stem-like cell rather than a progeny differentiated cell. We postulate that both known (e.g., HBV and HPV) and novel viruses (e.g., SARS-CoV-2) pose an imminent threat in the emergence of chronic viral diseases as well as virally induced malignancies. Knowing the origin of cancer has profound implications on our current conception and perception of cancer. It affects our conduct in cancer research and our delivery of cancer care. It would be ironic if viruses turn out to be a useful tool and an ideal means in our quest to verify a genetic versus stem cell origin of cancer. When it pertains, oncology recapitulates ontogeny; although genetic makeup is pivotal, cellular context may be paramount to elucidating a stem cell origin of cancer.